Latest filing published 26 Sept 2023 for Reata Pharmaceuticals INC.
Insider track record
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
William D. McClellan Jr.: trading record in brief
William D. McClellan Jr., listed as board member, has filed trades across 2 companies (mainly through SEC (Form 4)), most often in Reata Pharmaceuticals Inc and Apollo Endosurgery, Inc. In total, 27 filings cover trades dated from 16 May 2017 to 26 September 2023.
On the open market, the record shows 5 purchases worth €23k and 5 sales worth €1.8M. Taken together, the sales exceed the purchases by €1.8M. A purchase on the market is a deliberate choice to commit personal money, which is why it draws more attention than a grant. Besides market trades, the filings include 11 share grants. So far in 2023, the count stands at no purchases and 1 sale.
In size, the median ticket on the buying side is €2,770. Clusters matter here: 4 out of 4 purchases overlapped with buying by a colleague within 30 days. When several insiders buy within a few weeks of each other, analysts speak of a cluster purchase.
The newest entry dates from 26 September 2023: a transaction, in Reata Pharmaceuticals Inc. The clock since the last published purchase (30 May 2017) now reads 3,449 days. Filings reach the SEC (Form 4) feed a median of 2 days after the trade. For comparison, the SEC allows two business days to file a Form 4. Source: insider filings from SEC (Form 4). Past trades are no guide to future returns.
Companies and markets linked to William D. McClellan Jr.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
- 6,017 sharesClass A common stockSEC:0000899243-23-019534:0
- 5,000 sharesClass A common stockSEC:0001209191-23-043997:0
- 106 shares@ US$93.6143.3% of flowClass A common stockSEC:0001209191-23-035833:0
- 39,249 sharesCommon StockSEC:0001251769-23-000026:0
- 14,224 shares0Common StockSEC:0001251769-22-000056:0
- 287 shares@ US$34.7676.7% of flowClass A common stockSEC:0001209191-22-035412:0
- 59 shares@ US$27.327.1% of flowClass A common stockSEC:0001209191-22-001625:0
- 3,888 shares0Common StockSEC:0001251769-21-000085:0
8 of 8 declarations
